From the dried fruiting bodies of Ganoderma lucidum, 2 new unsaturated lactones, dayaolingzhilactones A and B (1 and 2), and 1 new meroterpenoid, dayaolingzhiol H (3), together with 10 known compounds (4-13), were isolated. Their chemical structures were identified by using spectroscopic data and calculated specific rotation. The inhibitory activities of compounds 1 and 2 toward acetylcholinesterase (AchE) were assessed in vitro with tacrine as the positive control. Both of them exhibited moderate AchE inhibitory activities at the concentration of 50 μM.
Ganoderma lucidum (Ganodermataceae), a fungus registered in the Pharmacopoeia of China and American Herbal Pharmacopoeia and Therapeutic Compendium, has been used in China for thousands of years for promoting health, longevity and spiritual growth. 1 Currently, it is widely used for the treatment of bronchitis, allergies, hepatitis, hypertension, immunological disorders, neurasthenia, and diabetes. 2, 3 Previous chemical studies revealed that polysaccharides and triterpenoids are the 2 main pharmacologically active constituents in G. lucidum. 4 In addition, a few other structural types of compounds have also been reported sporadically such as alkaloids, steroids, lactones, and fatty acids. 4 As part of our chemical studies on Ganoderma genus, the title material was investigated, resulting in the isolation of 2 new unsaturated lactones (1 and 2), a new meroterpenoid (3), along with 10 known compounds (4-13) (Figure 1) . Besides, the inhibitory activities of compounds 1 and 2 toward acetylcholinesterase (AchE) were assessed. Our efforts are described below.
Compound 1, a colorless oil, has the molecular formula C 15 3 carbon). The architecture of 1 was constructed by 2D NMR experiments. Interpretation of 1D and 2D NMR data discloses that the structure of compound 1 resembles that of 5-hydroxy-3,4-dimethyl-5-pentyl-2(5H)-furanone (4) 5 but differs in the structure of the side chain. Figure 2 ) correlations of H 2 -5/H 2 -6/H 2 -7 and H 2 -10/H 2 -11/H 2 -12, together with the HMBC correlations of H 2 -6/C-8, H 2 -11/C-9, and H 2 -11, H 2 -12/C-13 (δ C 178.4), suggest the length of the side chain, and the additional carboxylic acid group is at the terminal of the chain. In addition, HMBC correlations of H 3 -14/C-2, C-3, H 3 -15/C-2, C-3, C-4, and H 2 -5/C-4 secured the presence of an unsaturated 5-membered lactone. Thus, the planar structure of 1 has been deduced. Finally, there is 1 chiral center in the structure of 1; its absolute configuration at C-4 in 1 was identified as 4R by comparing its specific rotation { Table S1 ). Thus, the structure of 1, named dayaolingzhilactone A, was identified.
Compound 2 possesses a molecular formula of C 10 H 10 O 2 based on its HRESIMS, 13 C NMR, and DEPT data, with 6 degrees of unsaturation. No. (Figure 2) gives the correlations of H-2/H-3/H-4 and H-6/H-7/H-8/H-9/H 3 -10. The remaining 1 degree of unsaturation could be attributed to the presence of a ring formed by the oxygen bridge between C-1 (δ C 164.3) and C-5 (δ C 161.5), which was further certified by the HMBC correlations of H-2, H-3/C-1 and H-4, H-6/C-5. The couple constants of J 6,7 value (15.3 Hz) and J 8,9 value (16.2 Hz) suggest the configurations of the double bonds Δ 6(7) and Δ 8 (9) are both of trans-orientation. Thus, the structure of 2 was determined ( Figure 1) .
The molecular formula of compound 3 was determined to be C 21 H 28 O 6 (8 degrees of unsaturation) based on its HRESIMS, 13 C NMR, and DEPT data. (Figure 1) , and the HMBC correlations of H 2 -2′/C-2 and H-3/C-1′ suggest the side chain is attached to C-2. For the geometry of the double bonds, the ROESY correlations of H-6′/H 2 -8′ and H-10′/H 3 -13′ indicate that the configurations of the Δ 6′(7′) and Δ 10′(11′) double bonds are both E-form. Thus, the planar structure of 3 was deduced. Compound 3 was proved to be optically pure by chiral HPLC analysis, and its absolute configuration was determined as 3′R by comparing its optical rotation (OR) { 
6,7
The known compounds were identified by comparing their spectroscopic data with the literature data. They are 5-hydroxy-3,4-dimethyl-5-pentyl-2(5H)-furanone (4), 5 4-methoxy-6-styryl-2H-pyran-2-one (5), 8 ganoleucoin E (6), 9 ganoderal A (7), 10 ganoderol A (8), 11 ganoderic acid S (9), 11 ganoderic acid Y (10), 11 ganoderol B (11), 11 lumichrome (12), 12 and cinnamic acid (13). 13 In this study, only the new compounds with the exception of 3 were evaluated for their inhibitory property toward AchE. It was found that both of them (50 µM) exhibit moderate inhibitory activities with the inhibition rate of 49.69% ± 0.63% and 35.45% ± 3.37%, respectively (tacrine as a positive control with the inhibition rate of 60.68% ± 2.85% at the concentration of 0.33 µM).
Experimental

General
ORs were recorded on a Jasco P-1020 digital polarimeter. UV spectra were measured on a Shimadzu UV2401PC spectrometer. CD spectra were measured on an Applied Photophysics Chirascan instrument. NMR spectra were measured on a Bruker AV 400, or 600 MHz spectrometer, with TMS as an internal standard. ESIMS and HRESIMS were measured on an Agilent 1290 UPLC/6540 Q-TOF instrument. RP-18 (40-60 µm, Daiso Co., Japan), MCI gel CHP 20P (75-150 µm, Tokyo, Japan), silica gel GF254 (80-100 mesh, Qingdao Marine Chemical Inc., China), and Sephadex LH-20 (Amersham Biosciences, Sweden) were used for column chromatography. Semipreparative HPLC was carried out using an Agilent 1200 liquid chromatograph (Agilent Technologies, Santa Clara, CA, USA). The columns used were YMC-Pack ODS-A (250 mm × 10 mm, i.d., 5 µm) and Daicel Chiralpak IC (250 mm × 10 mm, i.d., 5 µm).
Fungal Material
The fruiting bodies of G. lucidum were collected from Dayao County of Yunnan Province, China, in December 2015. The material was identified by Prof Zhu-Liang Yang at Kunming Institute of Botany, Chinese Academy of Sciences, and a voucher specimen (CHYX0596) has been deposited at the School of Pharmaceutical Sciences, Shenzhen University, since November 2017.
Extraction and Isolation
The dried material (4.0 kg) was soaked with 80% EtOH (20 L × 3 × 24 hours) to give a crude extract, which was extracted with EtOAc to afford an EtOAc-soluble extract (0.12 kg). The EtOAc extract was divided into 10 parts (Fr.1-Fr.10) by using an MCI gel CHP 20P column chromatography eluted with aqueous MeOH (40%-100%). Fr.5 (5.1 g) was passed through Sephadex LH-20 (MeOH) to yield 4 fractions (Fr.5.1-Fr.5.4). Fr.5.2 (0.4 g) was further separated by preparative HPLC (MeOH/H 2 O, 60%) followed by semipreparative HPLC (ACN/H 2 O, 40%) to give 6 (1.3 mg, t R = 11.1 minutes, 3 mL/min). Fr.6 (3.7 g) was filtered by Sephadex LH-20 (MeOH) to give Fr.6.1 to Fr.6.6. Fr.6.3 (30.0 mg) was purified by semipreparative HPLC (ACN/H 2 O, 48%) to yield 2 (1.3 mg, t R = 14.3 minutes, 3 mL/min). Fr.6.4 (0.1 g) was first separated by preparative HPLC (MeOH/H 2 O, 60%) and then purified by semipreparative HPLC (ACN/H 2 O, 41%) to obtain 3 (2.6 mg, t R = 23.7 minutes, 3 mL/min). Fr.6.5 (80.0 mg) was also first separated by preparative Table 1 Computational Methods
The OR calculation was performed by a Gaussian 09 program package. The conformational search generating low-energy conformers within a 6 kcal/mol was deduced by Conflex 7 to optimize the low-energy conformations. Then, the OR calculations were conducted at the B3LYP/6-311G(d,p) level in MeOH, and the results were processed using previously described methods. 14 
Biological Evaluation
Inhibition of AchE was assayed using a microplate as previously described. 15, 16 The concentration of the compounds is 50 µM, and tacrine was used as a positive control with the concentration of 0.33 µM. The assay was done in triplicate and the results are expressed as mean ± SD.
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